Literature DB >> 8060313

A cell-binding Arg-Gly-Asp sequence is present in close proximity to the major linear antigenic region of HCV NS3.

Z X Zhang1, A Sönnerborg, M Sällberg.   

Abstract

By sequence analysis of the HCV NS3 protein we identified an Arg-Gly-Asp (RGD) motif, which is a known sequence for integrin-mediated cell adhesion, within a region of high hydrophilicity and surface probability. We therefore probed the complete NS3 protein for antigenic regions and cell binding activities using synthetic peptides. Antigenic regions were located to residues 1007-1022, 1047-1062, 1127-1142 and 1207-1232. The RGD-sequence reside two residues apart from the antigenic region at residues 1127-1142. Cell-adhesion experiments showed that NS3 peptides containing the RGD-sequence bound HUT-78 T-cells in a dose dependent manner. Antibodies to region 1127-1142 were found in all categories of HCV patients, arguing against the clinical significance of these antibodies. Extracellular NS3 proteins might disturb the migration of immune cells to the infected area by blocking the RGD-binding integrins, and thus, protect the infected cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060313     DOI: 10.1006/bbrc.1994.2079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Characterization of a monoclonal antibody and its single-chain antibody fragment recognizing the nucleoside Triphosphatase/Helicase domain of the hepatitis C virus nonstructural 3 protein.

Authors:  Z X Zhang; U Lazdina; M Chen; D L Peterson; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.

Authors:  Xiaozhen Zhang; Marybeth Daucher; David Armistead; Rodney Russell; Shyam Kottilil
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

3.  Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Authors:  Iram Gull; Muhammad Shahbaz Aslam; Imran Tipu; Roohi Mushtaq; Tehseen Zamir Ali; Muhammad Amin Athar
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

4.  HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor.

Authors:  Kotaro Sakata; Mitsuko Hara; Takaho Terada; Noriyuki Watanabe; Daisuke Takaya; So-ichi Yaguchi; Takehisa Matsumoto; Tomokazu Matsuura; Mikako Shirouzu; Shigeyuki Yokoyama; Tokio Yamaguchi; Keiji Miyazawa; Hideki Aizaki; Tetsuro Suzuki; Takaji Wakita; Masaya Imoto; Soichi Kojima
Journal:  Sci Rep       Date:  2013-11-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.